Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.
Arnaud
Laurent
L
Schartz
Noël E C
NE
Bousquet
Guilhem
G
Sarandi
Farid
F
Verola
Olivier
O
Madelaine
Isabelle
I
Kerob
Delphine
D
Lebbe
Céleste
C
D000008:Abdominal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003128:Coma / Q000139:chemically induced*; D017809:Fatal Outcome; D005260:Female; D005350:Fibroma / Q000188:drug therapy* / Q000601:surgery; D005354:Fibrosarcoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects*; D000077210:Sunitinib; D017211:Treatment Failure
D000970:Antineoplastic Agents; D007211:Indoles; D047428:Protein Kinase Inhibitors; D011758:Pyrroles; D011505:Protein-Tyrosine Kinases; D000077210:Sunitinib